### Popular Blood Pressure Medication Ziac Recalled Due to Contamination Fears Glenmark Pharmaceuticals has initiated a nationwide recall of its blood pressure medication, Ziac, after the U.S. Food and Drug Administration (FDA) detected cross-contamination with ezetimibe, a drug used to lower cholesterol. This recall affects over 11,100 bottles of Ziac tablets, which combine bisoprolol fumarate and hydrochlorothiazide. The FDA has classified this recall as Class III, indicating that exposure to the contaminated product is not likely to cause adverse health consequences, but patients are advised to check their medications and consult healthcare providers if they have the affected lots [https://www.independent.co.uk/news/health/blood-pressure-recall-ziac-cross-contamination-b2881303.html][https://www.mirror.co.uk/news/us-news/blood-pressure-medication-recalled-ziac-36383043.html]. ### Breakdown of the Recall Situation 1. **Nature of the Recall**: - Glenmark Pharmaceuticals has recalled Ziac due to contamination with ezetimibe, a cholesterol-lowering medication [https://www.dailyrecord.co.uk/news/uk-world-news/popular-blood-pressure-tablets-recalled-36378927.html]. - The FDA's testing revealed the presence of this drug in the blood pressure medication, prompting the recall [https://www.breitbart.com/politics/2025/12/09/fda-recalls-blood-pressure-medication-due-to-contamination]. 2. **Scope of the Recall**: - The recall affects more than 11,100 bottles of Ziac tablets across various lot numbers and bottle sizes [https://www.kgun9.com/life/recalls/thousands-of-blood-pressure-medication-bottles-recalled-due-to-contamination]. - Patients are encouraged to check their prescriptions against the recalled lot numbers and consult their pharmacists or healthcare providers [https://www.healthandme.com/health-news/fda-recalls-high-blood-pressure-medication-heres-why-article-153258982]. 3. **FDA Classification**: - The FDA has classified this recall as a Class III recall, which means that the use of or exposure to the violative product is not likely to cause adverse health consequences [https://peoplebugs.com/common-blood-pressure-drug-recalled-after-cross-contamination-the-times-of-india]. ### Supporting Evidence and Data - **Recall Details**: - Affected products include: - 30-tablet bottles (NDC 68462-878-30, Lot 17232401, exp. 11/2025) - 100-tablet bottles (NDC 68462-878-01, Lot 17232401, exp. 11/2025) - 500-tablet bottles (NDC 68462-878-05, Lot 17232401, exp. 11/2025) - 500-tablet bottles (NDC 68462-878-05, Lot 17240974, exp. 05/2026) [https://www.yardbarker.com/entertainment/articles/blood_pressure_drug_recall_glenmarks_ziac_contamination_alert/s1_17456_43169432]. - **Patient Guidance**: - Patients are advised to contact their pharmacist or prescriber if they have any of the recalled medications and to safely discard any affected tablets [https://www.usatoday.com/story/news/health/2025/12/06/blood-pressure-drug-recall-ziac-cross-contamination/87641330007]. ### Conclusion and Recommendations In summary, **Glenmark Pharmaceuticals has recalled Ziac due to contamination with ezetimibe**, a cholesterol medication, affecting over 11,100 bottles. The FDA has classified this as a Class III recall, indicating minimal risk to health. Patients should take immediate action to check their medications against the recalled lots and consult healthcare professionals for guidance. 1. **Immediate Action**: Check prescriptions for affected lot numbers. 2. **Consult Healthcare Providers**: Contact pharmacists or doctors for advice on next steps. 3. **Safe Disposal**: Discard any recalled medications safely. For further information, patients can refer to the FDA's official announcements and Glenmark's communications regarding the recall [https://www.iheart.com/content/2025-12-09-popular-medication-recalled-for-possible-cross-contamination].